baber/WOPTO huggingface dataset:
Patent MX-157183-A (MX)
Inventor: LUGERI THOMAS JOSEPH
IPC: A41B9/12
Filed: 1983-08-31
Abstract: A thin absorbent undergarment liner is provided which exhibits a clear, aesthetically pleasing embossed pattern on the body facing surface thereof while still maintaining the longitudinal edges soft and comfortable. The liner is provided to have areas of deep depressions on the body facing surface and shallow impressions on the longitudinal edges.
Patent NZ-199650-A (NZ)
Title: 2-(4-(diphenylmethyl)-1-piperazinyl)-acetic acid derivatives
Inventor: BALTES EUGENE
IPC: C07D295/08
Filed: 1982-02-05
Abstract: New 2-[4-(diphenylmethyl)-1-piperazinyl]-acetic acids, their amides and their salts, processes for the preparation thereof and therapeutic compositions. These compounds have the formula   <IMAGE> wherein Y=-OH or -NH2; X and X'=H, halogen, alkoxy or trifluoromethyl; m=1 or 2 and n=1 or 2. The amides of the 2-[4-(diphenylmethyl)-1-piperazinyl]-acetic acids are prepared either by reacting a 1-(diphenylmethyl)-piperazine with an omegahaloacetamide, or by reacting an alkali metal salt of an omega-[4-(diphenylmethyl)-1-piperazinyl]-alkanol with a 2-haloacetamide, or yet by reacting ammonia with a halide or alkyl ester of a 2-[4-(diphenylmethyl)-1-piperazinyl]-acetic acid, whereas the 2-[4-(diphenylmethyl)-1-piperazinyl]-acetic acids are prepared by hydrolyzing the corresponding amide or lower alkyl ester. These compounds have in particular an antiallergic, spasmolytic and antihistaminic activity.
Patent NZ-206870-A (NZ)
Title: 2-(3-pyridyl)-1,3,4-thiadiazole and 5-(3-pyridyl)-1,2,4-thiadiazole derivatives and pesticidal compositions
Inventor: KRISTIANSEN O
IPC: C07D401/04
Filed: 1984-01-18
Abstract: for all contracting states except AT 1. The use of a compound of the formula I   see diagramm : EP0116515,P15,F1   wherein R1  is   see diagramm : EP0116515,P15,F2   and R2  and R3  are hydrogen or C1 -C4  alkyl, or of a composition containing such a compound, for controlling representatives of the order Acarina and insects that attack plants and animals. for the contracting state : AT 1. The use of a compound of the formula I   see diagramm : EP0116515,P18,F1   wherein R1  is   see diagramm : EP0116515,P15,F2   and R2  and R3  are hydrogen or C1 -C4 -alkyl, or of a composition containing such a compound, for controlling representatives of the order Acarina and insects that attack plants and animals.
Patent NZ-209966-A (NZ)
Title: Dual display programmable time switch
Inventor: FAERESTRAND W A
IPC: G04G9/00
Filed: 1984-10-23
Abstract: The timeswitch comprises a switch actuated in accordance with a pre-set switching program, by microprocessor controlled circuitry, and a display 10 comprising an analogue time display portion 10a. The analogue portion 10a comprises inner and outer concentric circles of actuable indicia 12, 14. In the running mode of the timeswitch, in one configuration, the indicia 14 of the inner circle are sequentially actuated to represent the hour hand of an analogue clock displaying the actual time. The outer indicia 12 are actuated in groups to represent the switching program <<on>> times. In the programming mode, the time indicated by the inner indicia 14 may be manually selected, whereafter the state of the switch at that time may be selected. The outer indicia 12 are actuated in sets to represent the switching program being entered. Other configurations of the timeswitch are possible according to the microprocessor software, and some examples are described.
Patent NZ-210974-A (NZ)
Title: Absorbent laminates
Inventor: BRASSINGTON N J
IPC: B32B9/02
Filed: 1985-01-28
Abstract: Absorbent laminates, which may be used as or in diapers, incontinence pads, sanitary napkins, tampons or wound dressings, comprise a hydrophilic layer (1) adjacent a water-permeable fibrous web (3). Fluid-transporting wicks extend from within the fibrous web into the hydrophilic layer, and are preferably formed by needling. The hydrophilic layer is preferably a peat moss composite board, and the fibrous web is preferably a nonwoven polyester fleece.
Patent NZ-214894-A (NZ)
Title: Paste extruder: nozzle output controlled by plug valves
Inventor: LEE R D
IPC: A21C9/06
Filed: 1986-01-21
Abstract: Edible paste enters an apparatus at an inlet. A nut holds the inlet coupled to another supply pipe. A portion of the nut is threaded. The area of the inlet is approximately equal to the area of a slit-like opening, the filling material or edible paste passing through the slit and into an opening in a block. A second block has a plurality of valves therein, the valves being simple plug valves, and having a single bore therethrough. Paste is extruded through nozzles fixedly connected to a third block, and paste is extruded into rows upon a moving bed of a lower half portion of a continuous sheet of "shredded wheat" in its uncut form. The paste is laid in rows of five across, and a second sheet of uncut shredded wheat is laid atop the first layer, trapping the rows of paste. The resulting product when cut forms the familiar shredded wheat biscuit shape. The finished product contains raisin paste.
Patent NZ-221752-A (NZ)
Title: Bonding ceramic bodies by heating in presence of vapour-phase oxidant
Inventor: LUSZCZ STANLEY J
IPC: C04B35/65
Filed: 1987-09-09
Abstract: Ceramic bodies are bonded by providing a first body formed of polycrystalline material and interconnected residual metal formed by the oxidn. reaction of molten metal and a vapour phase oxidant and grown as molten metal is transported through and then oxidised on the surface of its own oxidn. reaction prod.; holding a second ceramic body against a surface of the first; and heating so that the residual metal content of the first body is transported to the interface where an oxidn. reaction prod. continues to grown as above and forms a bond. - Specifically the metal is Al, oxidant is air and oxidn. reaction prod. is Al2O3. The first body may be formed by infiltrating a filler with oxidn. reaction prod. A barrier material, pref. Ca sulphate, silicate or phosphate or Portland cement, is used to embed and surround all surfaces of the first body except the contacting surface. A body of metal may be placed in contact with another surface of the first body embedded in the barrier material, so that the metal melts and is transported to the bonding interface during the heating step. The second body may have the same ceramic compsn. as the first; it may be made by a different method; or may be of a different compsn. but made by the same method. Pref. the reaction prod. is an oxide, nitride or carbide and the metal is Ti, Si, Zr, Hf or Sn.
Patent NZ-223151-A (NZ)
Title: Leukotriene antagonists with a 2,4,5 substitution pattern on the phenolic ring
Inventor: BOLLINGER N G
IPC: C07C235/18
Filed: 1988-01-11
Abstract: This invention provides benzene derivatives of the Formula I <CHEM> pharmaceutical formulations of those derivatives, and a method of using the derivatives for the treatment of inflammation in mammals.
Patent NZ-227359-A (NZ)
Title: Heterocyclic substituted cyclohexane (or cycloheptane) thioformamide derivatives and pharmaceutical compositions
Inventor: COOK DAVID CHARLES
IPC: C07D215/14
Filed: 1988-12-16
Abstract: Therapeutically useful thioformamide derivatives of the formula: <CHEM> wherein R represents alkyl, Het represents pyrid-3-yl, isoquinolin-4-yl, tetrahydroquinolin-3-yl, quinolin-3-yl, pyridazin-4-yl, pyrimid-5-yl, thiazol-5-yl, thieno[2,3-b]pyridin-5-yl, pyrazin-2-yl, indol-3-yl and thieno[3,2-b]pyridin-6-yl, Y represents ethylene, methylene or a valency bond, and X represents carbonyl, hydroxymethylene, >C=NOR<1>, >C=NN(R<1>)2 or >C=NN(R<1>)CON(R<1>)2 in which R<1> represents hydrogen or optionally substituted alkyl, benzyl, phenethyl, 1-naphthylmethyl, 2-naphthylmethyl or pyrid-3-ylmethyl, or two R<1> substituents on the same nitrogen atom may together form an optionally substituted alkylene radical chain and salts thereof, processes for their preparation and compositions containing them are described.
Patent NZ-235583-A (NZ)
Title: (endo)-n-(((8-methyl-8-azabicyclo(3.2.1)octan-3-yl)amino)carbonyl)-2-(cyclopropylmethoxy)benzamide; preparation thereof and pharmaceutical compositions
Inventor: WARD TERENCE JAMES
IPC: A61K31/00
Filed: 1990-10-05
Abstract: (Endo)-N-[[(8-methyl-8-azabicyclo[3.2.1]octan-3-yl)amino]carbonyl]-2-( cyclop r opylmethoxy)benzamide and its pharmaceutically acceptable acid addition salts are useful as 5-HT3-antagonists, e.g. in the treatment of anxiety.
Patent NZ-235933-A (NZ)
Title: Use of setraline
Inventor: DOOGAN DECLAN P
IPC: A61K31/13
Filed: 1990-11-01
Abstract: The use of the compound (1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine or a pharmaceutically acceptable salt thereof for the manufacture of a medicament to treat or prevent social phobia and the symptoms associated with such a disorder.
Patent NZ-237824-A (NZ)
Title: Formulation for oral administration comprising a core of active ingredient coated by a polymer soluble at ph greater than 5 and containing an acidic compound to prevent dissolution of the coating in the mouth
Inventor: MAPELLI LUIGI GIOVANNI
IPC: A61K9/00
Filed: 1991-04-15
Abstract: PCT No. PCT/EP91/00689 Sec. 371 Date Dec. 11, 1991 Sec. 102(e) Date Dec. 11, 1991 PCT Filed Apr. 9, 1991 PCT Pub. No. WO91/16043 PCT Pub. Date Oct. 31, 1991.The taste of orally administered drugs is masked by coating the drug with a polymeric membrane which is soluble only at a pH of 5 or more. An acid substance is included in the formulation containing the coated drug to reduce or prevent the dissolution of the membrane in the oral cavity.
Patent NZ-240779-A (NZ)
Title: Process for forming a cobalt conversion coating on a metal substrate (for corrosion resistance and paint adhesion); coated article
Inventor: SCHRIEVER MATTHIAS P
IPC: C23C22/05
Filed: 1991-11-28
Abstract: (A.) A process for forming a cobalt conversion coating on a metal substrate, thereby imparting corrosion resistance and paint adhesion properties. The invention was developed as a replacement for the prior art chromic acid process. The process includes the steps of: (a) providing a cobalt conversion solution comprising an aqueous solution having a pH of about 7.0 to 7.2 and containing a soluble cobalt-III hexacoordinated complex, the concentration of the cobalt-III hexacoordinated complex being from about 0.1 mole per gallon of solution to the saturation limit of the cobalt-III hexacoordinated complex; and (b) contacting the substrate with the solution for a sufficient amount of time, whereby the cobalt conversion coating is formed. The substrate may be aluminum or aluminum alloy, as well as magnesium and its alloys, Cd plated substrates, and Zn plated substrates. The cobalt-III hexacoordinated complex may be present in the form of Me3[Co(NO2)6] wherein Me is one or more of Na, K, and Li. (B.) A chemical conversion coating solution for producing the cobalt conversion coating on a metal substrate, the solution being an aqueous solution having a pH of about 7.0 to 7.2 and containing a soluble cobalt-III hexacoordinated complex, the concentration of the cobalt-III hexacoordinated complex being from about 0.1 mole per gallon of solution to the saturation limit of the cobalt-III hexacoordinated complex. The cobalt conversion solution may be prepared by a bath makeup sequence including the steps of: (a) dissolving a metal nitrite salt; (b) dissolving an accelerator such as NaI; (c) dissolving a cobalt-II salt; and (d) then adding an oxidizer such as H2O2. (C.) A coated article exhibiting corrosion resistance and paint adhesion properties, the article including: (a) a metal substrate; and (b) a cobalt conversion coating formed on the substrate, the cobalt conversion coating including aluminum oxide Al2O3 as the largest volume percent, and cobalt oxides CoO, Co3O4, and Co2O3. <IMAGE>
Patent NZ-271488-A (NZ)
Title: Connective tissue growth factor-2 (ctgf-2)
Inventor: LI HAODONG
IPC: A61K8/00
Filed: 1994-07-12
Abstract: The present invention relates to a human CTGF-2 polypeptide and DNA (RNA) encoding such polypeptide. Also provided is a procedure for producing such polypeptide by recombinant techniques and antibodies and antagonist/inhibitors against such polypeptide. Also provided are methods of using the polypeptide therapeutically for enhancing the repair of connective and support tissue, promoting the attachment, fixation and stabilization of tissue implants and enhancing wound healing.
Patent NZ-273706-A (NZ)
Title: Closed cell foam prepared by transferring homogenised plastics/chemical blowing agent mixture to a closed mould at a temperature above the decomposition temperature, the mould being opened when a predetermined decomposition is reached
Inventor: SPYDEVOLD STEINAR
IPC: B29C67/20
Filed: 1994-09-14
Abstract: PCT No. PCT/NO94/00153 Sec. 371 Date Mar. 4, 1996 Sec. 102(e) Date Mar. 4, 1996 PCT Filed Sep. 14, 1994 PCT Pub. No. WO95/07812 PCT Pub. Date Mar. 23, 1995A process for the production of products of light cellular plastic with closed cells from a plastic composition containing chemical blowing agent and, optionally, other process-regulative substances and additives, where the plastic composition is processed (kneaded) mechanically in a plastic processing machine to a well homogenized, melted plastic compound, and that the plastic compound is then pressed into a closed cavity, at a temperature above the decomposition temperature for the chemical blowing agent in the plastic compound, in combination with possible decomposition regulative additives.
Patent NZ-276631-A (NZ)
Title: Isoxazoline derivatives and medicaments
Inventor: WITYAK JOHN
IPC: A61K31/5377
Filed: 1994-11-14
Abstract: This invention relates to novel isoxazolines which are useful as antagonists of the platelet glycoprotein IIb/IIIa fibrinogen receptor complex, to pharmaceutical compositions containing such compounds, processes for preparing such compounds, and to methods of using these compounds, alone or in combination with other therapeutic agents, for the inhibition of platelet aggregation, as thrombolytics, and/or for the treatment of thromboembolic disorders.
Patent NZ-301067-A (NZ)
Title: Cytokine designated lerk-7 for activating tyrosine kinases
Inventor: CERRETTI DOUGLAS PAT
IPC: C07K16/24
Filed: 1995-12-05
Abstract: The invention is directed to a protein designated Lerk-7, DNA encoding the Lerk-7, and host cells transformed with Lerk-7 DNA. Antibodies directed against Lerk-7 are also provided. The Lerk-7 protein binds to the cell surface receptors known as elk and hek.
Patent NZ-337553-A (NZ)
Title: High homogeneity of the alloys produced compared to traditional melting technology due to low rates of metal transfer and coupled with electromagnetic stirring of the liquid metal pool
Inventor: GINATTA MARCO VINCENZO
IPC: C25C/
Filed: 1998-01-08
Abstract: A process for the electrolytic production of metals particularly titanium and alloys starting from the its respective metals, by means of an apparatus for the electrochemical extraction including: (1) a cathode-crucible containing a mass of solidified metal, a liquid electrolyte with a density which is lower than that of the metal and a pool of liquid metal produced; (2) one or more non-consumable anodes particularly immersed in the electrolyte with means for regulating their distance from the cathodic surface; (3) a feeding system to the electrolyte of the compounds of the metals, of the electrolyte constituents and of alloying materials; (4) a power supply which feeds direct current to the liquid metal, and through the electrolyte, to the anodes, and causes the cathodic reduction of the metal in liquid form and the evolution of anodic gas, with the heat generation which maintains the electrolyte in the molten state; and (5) an air-tight containment structure in which the anodic gases generated during the electrolysis are collected.
Patent NZ-337640-A (NZ)
Title: Method for reproducing hair follicle cells from anagenetic hairs in the anagen phase
Inventor: GHO CONRADUS GHOSAL
IPC: A61F2/10
Filed: 1998-03-05
Abstract: Method of reproduction of hair, which method comprises the following steps:(1) removal of hair in the anagen phase from one or more donor regions in such a way that the bulb characteristic of hair in the anagen phase is still attached to the hair removed,(2) culture of hair follicle cells from the hair removed, under conditions such that the hair follicle cells are able to multiply, and(3) implantation of the cultured hair follicle cells in the receptor regions.Medium which comprises at least one suitable serum-free keratinocyte culture medium and extracts of at least one human mast cell line and method for culturing hair follicle cells from hairs in the anagen phase, wherein one or more hairs in the anagen phase are placed in said medium.
Patent NZ-501345-A (NZ)
Title: Treatment of diabetes mellitus with 5-[4-[2-(N-methyl-N-(2- pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione (2-12 mg) and an alpha-glucosidase inhibitor antihyperglycemic agent
Inventor: SMITH STEPHEN ALISTAIR
IPC: A61K31/44
Filed: 1998-07-15
Abstract: A method for the treatment of diabetes mellitus and associated conditions in a mammal, which comprises administering an effective non-toxic and pharmaceutically acceptable amount of an insulin sensitiser and an alpha-glucosidase inhibitor antihyperglycaemic agent, to a mammal in need thereof. The insulin sinsitiser is 5-[4-[2-(N-methyl-N-(2- pyridyl)amino) ethoxy]benzyl]thiazolidine-2,4-dione (Compound (I) of EP 0306228) and is present in the medicament in amounts of 2 to 12 mg. The alpha-glucosidase inhibitor could be acarbose, emiglitate or miglitol.
Patent NZ-502056-A (NZ)
Title: Indole derivatives for antagonising an MCP-1 mediated effect
Inventor: BARKER ANDREW JOHN
IPC: A61P11/06
Filed: 1998-08-04
Abstract: In formula (I):  R1 is trifluoromethyl, C1-4alkyl, halo, hydroxy, C1-4alkoxy, C1-4alkanoyl, C1-4alkanoyloxy, carboxy, trifluoromethoxy, amino, cyano, C1-4alkylamino, di(C1-4alkyl)amino, C1-4alkanoylamino, nitro, carbamoyl, C1-4alkoxycarbonyl, thiol, C1-4alkylsulphanyl, C1-4alkylsulphinyl, C1-4alkylsulphonyl, sulphonamido, carbamoylC1-4alkyl, N-(C1-4alkyl)carbamoylC1-4alkyl, N-(C1-4alkyl)2carbamoyl-C1-4alkyl, hydroxy C1-4alkyl, C1-4alkoxyC1-4alkyl, morpholino, pyrrolidinyl, carboxyC1-4alkylamino, R3 or -OR3 (where R3 is optionally substituted aryl or an optionally substituted 5- or 6- membered heteroaryl ring); p is 0-4; (when p is 2-4, no more than one R1 can be chosen from the group amino, C1-4alkylamino, di(C1-4alkyl)amino, morpholino and pyrrolidinyl); T is of the formula -(CHR4)m-, where R4 is hydrogen or C1-4alkyl and m is 1-3; X is CO2R4, SO3H, cyano, -SO2NHR4 (where R4 is as defined above), -SO2NHAr (where Ar is an optionally substituted phenyl or optionally substituted 5 or 6 membered heteroaryl ring), -CONHR5 (where R5 is H, cyano, C1-4alkyl, OH, -SO2-C1-4alkyl, -SO2CF3, -SO2-phenyl, (CHR4)n-COOH, (where n is 1-3), or X is a group of formula (II) or formula (III) depicted above; A is phenyl, naphthyl, furyl, pyridyl or thienyl; R2 is trifluoromethyl, C1-4alkyl, halo, hydroxy, CF3O-, C1-4alkoxy, C1-4alkanoyl, C1-4alkanoyloxy, amino, cyano, C1-4alkylamino, (C1-4alkyl)2amino, C1-4alkanoylamino, nitro, carboxy, carbamoyl, C1-4alkoxycarbonyl, thiol, C1-4alkylsulphanyl, C1-4alkylsulphinyl, C1-4alkylsulphonyl, sulphonamido, carbamoylC1-4alkyl, N-(C1-4alkyl)carbamoylC1-4alkyl, N-(C1-4alkyl)2carbamoyl-C1-4alkyl, hydroxyC1-4alkyl, C1-4alkoxyC1-4alkyl or two R2 values together may form a divalent radical of the formula -O(CH2)1-4O- attached to adjacent carbon atoms on ring A; q is 0-4; and Z is hydrogen, fluoro, chloro, bromo, iodo, methyl, trifluoromethyl, hydroxymethyl, acetyl, carboxyC3-6cycloalkyl or -(CHR4)r-NR6R7 (where r is 0-2, R6 and R7 are H or C1-4alkyl or R6 and R7 together with the nitrogen to which they are attached form a 5 or 6 membered non-aromatic ring optionally containing one further heteroatom selected from O, N or S). The compounds may be used in the treatment of a disease or condition mediated by monocyte chemoattractant protein-1 (MCP-1).  Particular conditions include rheumatoid arthritis, glomerular nephritides, lung fibrosis, restenosis, alveolites, asthma, atherosclerosis, psoriasis, delayed-type hypersensitivity reactions of the skin, inflammatory bowel disease, multiple sclerosis, brain trauma, stroke, reperfusion injury, ischemia, myocardial infarction and transplant rejection.
Patent NZ-504591-A (NZ)
Title: Drill bits and holders having a shank with driving keyways of a different cross section
Inventor: HOWARD DOUGLAS JAMES
IPC: B25D17/02
Filed: 1998-11-25
Abstract: A drill bit comprising of a shank (2) of nominal 10mm diameter for engagement within a tool holder (20), the shank comprising diametrically-opposed driving keyways (4,6) opening onto an end face of the shank and at least one locking groove (12) spaced from the end of the shank, the two driving keyways being of different cross section.  For each driving keyways the radial distance between the axis of the shank and the base of the keyway is not less than 2.25mm and not greater than 3.25mm.
Patent NZ-506845-A (NZ)
Title: Single use feed bottles for babies
Inventor: WILLIAMS STEPHEN JAMES
IPC: A61J11/00
Filed: 1999-02-18
Abstract: A  feed and drink bottle is made of plastics  material preferably  by  an aseptic process. In its  basic  form  the bottle  (2)  has a mouth (4) intended to be  sealed  with  a closure  (10) put in place after the feed has  been  put  in the  bottle through its mouth. The bottle is rendered  unfit for  re-use  as  a baby's bottle, thus making it  disposable either  by  preventing the closure from  being  able  to  be removed from the body of the bottle once it has reached  its fully  engaged  position,  or by preventing  it  from  being replaced  in  a  fluid  tight  position  once  it  has  been removed. The closure (10) has a teat (24) secured to  it  in an  irremovable manner, as by the teat being clamped between the  closure and a retainer member (18) held in place in the closure, or by the teat's being bonded to the closure.  When the  closure and teat are formed as a single unit, the  unit may  be  used  more  than  once on a  body  (2)  of  aseptic plastics  material,  thus  putting  back  on  the  user  the responsibility  of  ensuring that the  body  is  sterile  or aseptic before such re-use.
Patent NZ-507209-A (NZ)
Title: Vented electrical light housing
Inventor: EVERETT ROYCE WARREN
IPC: F21S2/00
Filed: 2000-09-29
Abstract: A lamp housing including a heat venting arrangement. The lamp housing provides hot air vents in its upper portion, consisting of one or more plates (5,7), which are spaced apart using nuts (6). Apart from the top plate (5) all plates are hollow, so as to allow hot air to flow up from the lamp. When installed the housing may be embedded in the ceiling and hot air can vent into the ceiling cavity.